Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

New therapeutic agents for ocular disorders disclosed in recent patent literature

Jan. 22, 2007

Vismed begins phase III study in dry eye syndrome

Jan. 19, 2007

Lux receives orphan drug designations for ophthalmic products

Jan. 18, 2007

New treatment for macular degeneration reported by Nippon Soda

Jan. 18, 2007

U.S. orphan drug designation for LX-211 in uveitis

Jan. 17, 2007

Fovea licenses RdCVF therapy for retinal degeneration

Jan. 17, 2007

rEV-131 misses primary endpoint in phase II postcataract inflammation trial

Jan. 12, 2007

New phase IIb trial begins for microplasmin in vitrectomy

Jan. 9, 2007

Inspire updates progress in dry eye program

Jan. 8, 2007

Major bear bile component may be useful to prevent retinal degeneration

Jan. 5, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...